Up a level |
Munir, Talha, Cairns, David A, Bloor, Adrian, Allsup, David, Cwynarski, Kate, Pettitt, Andrew ORCID: 0000-0002-0907-8950, Paneesha, Shankara, Fox, Christopher P, Eyre, Toby A, Forconi, Francesco ORCID: 0000-0002-2211-1831 et al (show 23 more authors)
(2024)
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
The New England journal of medicine, 390 (4).
pp. 326-337.
Bloehdorn, Johannes, Braun, Andrejs, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz et al (show 24 more authors)
(2021)
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
NATURE COMMUNICATIONS, 12 (1).
5395-.
Di Mambro, Antonella ORCID: 0009-0003-1157-216X, Arroyo-Berdugo, Yoana ORCID: 0000-0003-3268-1616, Fioretti, Tiziana, Randles, Michael, Cozzuto, Luca, Rajeeve, Vinothini ORCID: 0000-0002-6361-4291, Cevenini, Armando, Austin, Michael J ORCID: 0000-0003-4218-0284, Esposito, Gabriella, Ponomarenko, Julia et al (show 7 more authors)
(2023)
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
Oncogene, 42 (50).
pp. 3670-3683.